Office of National Drug Control Policy Reauthorization Act of 2024

house

senate

president

Legislation Details

Amends the Office of National Drug Control Policy Reauthorization Act of 1998 to reauthorize the Office.
Updates terminology and definitions related to drug control, including “emerging drug threat” and “precursor chemical.”
Expands the scope of the Office’s responsibilities to include tertiary prevention support and harm reduction activities.
Requires coordination with various federal agencies regarding drug control and enforcement activities.
Mandates the inclusion of opioid antagonists and overdose reversal agents in drug control strategies.
Establishes funding allocations for various drug control initiatives, including specific amounts for fentanyl interdiction activities.
Introduces provisions for temporary reassignment of assistant U.S. attorneys to prioritize fentanyl trafficking cases.
Requires reports on the use of funds for fentanyl interdiction and the effectiveness of drug control strategies.
Reauthorizes community-based coalition grants and increases funding for anti-drug initiatives.
Mandates a report on the availability and accessibility of life-saving opioid overdose reversal medications.

Amends the Office of National Drug Control Policy Reauthorization Act of 1998 to reauthorize the Office.
Updates terminology and definitions related to drug control, including “emerging drug threat” and “precursor chemical.”
Expands the scope of the Office’s responsibilities to include tertiary prevention support and harm reduction activities.
Requires coordination with various federal agencies regarding drug control and enforcement activities.
Mandates the inclusion of opioid antagonists and overdose reversal agents in drug control strategies.
Establishes funding allocations for various drug control initiatives, including specific amounts for fentanyl interdiction activities.
Introduces provisions for temporary reassignment of assistant U.S. attorneys to prioritize fentanyl trafficking cases.
Requires reports on the use of funds for fentanyl interdiction and the effectiveness of drug control strategies.
Reauthorizes community-based coalition grants and increases funding for anti-drug initiatives.
Mandates a report on the availability and accessibility of life-saving opioid overdose reversal medications.